Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Oil’s 7-Week Hurrah Ends With New Covid Strain

Published 12/24/2020, 01:27 PM
Updated 12/24/2020, 01:27 PM
© Reuters.

By Barani Krishnan

Investing.com - Crude prices rose Thursday but were unable to extend their seven-week rally as a new strain of the coronavirus discovered in Britain and feared to be spreading brought an unceremonious end to oil’s longest winning streak since April 2019.

Wildly surging U.S. case counts of the original Covid-19 virus also dampened the enthusiasm of oil bulls despite supportive inventory data for last week released by the government on Wednesday.

New York-traded WTI, the key indicator for U.S. crude, settled up $1.10, or 2.3%, at $48.12 per barrel. For the week, however, it fell 2%.

London-traded Brent, the global benchmark for crude, was up 10 cents, or 0.2%, at $51.34 by 1:17 PM ET (18:37 GMT). For the week, it slid 2.2%

The week was shortened by Friday's Christmas holiday.

Prior to that, oil prices had rallied seven weeks in a row on bets that people across the world might soon be able to travel freely as millions of doses of coronavirus vaccines were prepared for delivery after approval by relevant health authorities.

The rally was halted by this week's news that countries across Europe and beyond had barred U.K. travelers to prevent the spread of a new Covid-19 strain discovered in Britain. U.K. health authorities said the new variant was 70% more transmissible.

The U.S. Centers for Disease Control and Prevention also warned earlier this week that the new strain of the virus was probably already in America, only undetected.

Oil's weekly loss came despite the U.S. Energy Information Administration reporting on Wednesday largely positive inventory numbers for crude, gasoline and diesel-led distillates during the week ended Dec. 18.

 

Latest comments

Please STOP calling it a "strain" when it only a 'variant'. There is a big difference and the fear monger media are not helpful at all with their constant mis-quotes and biased misrepresentations.
"A new 'variant strain' of SARS-CoV-2 that contains a series of mutations has been described in the United Kingdom (UK) and become highly prevalent in London and southeast England." That's CDC language, Mr Asher. Maybe the media has leaned more on the latter part of that 'variant strain' than it ought to have. But what's the big deal you're trying to make here. The story is about the fear-factor behind the development, not the semantics around it.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.